Diabetic kidney disease (DKD) is one of the most common chronic microvascular complications of diabetes. In addition to the characteristic clinical manifestations of proteinuria, it also has a complex pathological process that results from the combined effects of multiple factors involving the whole renal structure such as glomeruli, renal tubules, and blood vessels. Non-coding RNAs (ncRNA) are transcripts with no or low coding potential, among which micro RNA (miRNA) has been widely studied as a functional miRNA involved in regulation and a potential biomarker for disease prediction. The abundance of long coding RNA (lncRNA) in vivo is highly expressed with a certain degree of research progress, but the structural similarity makes the research still challenging. The research of circular RNA (circRNA) is still in its early stages. It is more relevant to the study to provide a more relevant link between diseases in the kidney and other tissues or organs. This classification review mainly summarized the biogenesis characteristics, the pathological mechanism of ncRNA-regulating diseases, the ways of ncRNA in the clinical prediction as a potential biomarker, and the interaction networks of ncRNA.
Get full access to this article
View all access options for this article.
References
1.
AbdolrasouliA., PetrouM.A., ParkH., RhodesJ.L., RawsonT.M., MooreL.S.P., et al. (2018). Surveillance for Azole-Resistant Aspergillus fumigatus in a Centralized Diagnostic Mycology Service, London, United Kingdom, 1998–2017. Front Microbiol 9,2234.
2.
AfkarianM., ZelnickL.R., HallY.N., HeagertyP.J., TuttleK., WeissN.S., et al. (2016). Clinical manifestations of kidney disease among US Adults With Diabetes, 1988–2014. JAMA, 316, 602–610.
3.
AliP.S.S., GhoshdastiderU., HoffmannJ., BrutschyB., and FilipekS. (2012). Recognition of the let-7g miRNA precursor by human Lin28B. FEBS Lett, 586, 3986–3990.
4.
AlicicR.Z., RooneyM.T., and TuttleK.R. (2017). Diabetic Kidney Disease: challenges, Progress, and Possibilities. Clin J Am Soc Nephrol, 12, 2032–2045.
5.
AlvarezM.L., and DiStefanoJ.K. (2011). Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy. PLoS One 6,e18671.
6.
AlvarezM.L., KhosroheidariM., EddyE., and KieferJ. (2013). Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy. PLoS One 8,e77468.
7.
AlvarezM.L., KhosroheidariM., EddyE., KieferJ., and DiStefanoJ.K. (2016). Correction: role of MicroRNA 1207-5P and Its Host Gene, the Long Non-Coding RNA Pvt1, as Mediators of Extracellular Matrix Accumulation in the Kidney: implications for Diabetic Nephropathy. PLoS One 11,e0168353.
8.
ArgyropoulosC., WangK., McClartyS., HuangD., BernardoJ., EllisD., et al. (2013). Urinary microRNA profiling in the nephropathy of type 1 diabetes. PLoS One 8,e54662.
9.
AuyeungV.C., UlitskyI., McGearyS.E., and BartelD.P. (2013). Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing. Cell, 152, 844–858.
10.
BaiX., GengJ., LiX., WanJ., LiuJ., ZhouZ., et al. (2018). Long Noncoding RNA LINC01619 Regulates MicroRNA-27a/Forkhead Box Protein O1 and endoplasmic reticulum stress-mediated podocyte injury in diabetic nephropathy. Antioxid Redox Signal, 29, 355–376.
BaruttaF., BrunoG., MatulloG., ChaturvediN., GrimaldiS., SchalkwijkC., et al. (2017). MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study. Acta Diabetol, 54, 133–139.
13.
BaruttaF., TricaricoM., CorbelliA., AnnaratoneL., PinachS., GrimaldiS., et al. (2013). Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS One 8,e73798.
14.
BoutetA., De FrutosC.A., MaxwellP.H., MayolM.J., RomeroJ., and NietoM.A. (2006). Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J, 25, 5603–5613.
15.
BrennanE.P., NolanK.A., BorgesonE., GoughO.S., McEvoyC.M., DochertyN.G., et al. (2013). Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFbetaR1. J Am Soc Nephrol, 24, 627–637.
16.
BrownleeM. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414, 813–820.
17.
CabiliM.N., TrapnellC., GoffL., KoziolM., Tazon-VegaB., RegevA., et al. (2011). Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev, 25, 1915–1927.
18.
CaiX., HagedornC.H., and CullenB.R. (2004). Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA, 10, 1957–1966.
19.
CarninciP., KasukawaT., KatayamaS., GoughJ., FrithM.C., MaedaN., et al. (2005). The transcriptional landscape of the mammalian genome. Science, 309, 1559–1563.
20.
ChenB., LiY., LiuY., and XuZ. (2019a). circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells. J Cell Physiol, 234, 21249–21259.
21.
ChenF., WeiG., ZhouY., MaX., and WangQ. (2019b). The mechanism of miR-192 in regulating high glucose-induced MCP-1 expression in rat glomerular mesangial cells. Endocr Metab Immune Disord Drug Targets, 19, 1055–1063.
22.
ChenT., YuQ., XinL., and GuoL. (2020). Circular RNA circC3P1 restrains kidney cancer cell activity by regulating miR-21/PTEN axis and inactivating PI3K/AKT and NF- kB pathways. J Cell Physiol, 235, 4001–4010.
23.
ChengY., LuoW., LiZ., CaoM., ZhuZ., HanC., et al. (2019). CircRNA-012091/PPP1R13B-mediated lung fibrotic response in silicosis via endoplasmic reticulum stress and autophagy. Am J Respir Cell Mol Biol, 61, 380–391.
24.
ConradT., MarsicoA., GehreM., and OromU.A. (2014). Microprocessor activity controls differential miRNA biogenesis In Vivo. Cell Rep, 9, 542–554.
25.
DasS., ReddyM.A., SenapatiP., StapletonK., LantingL., WangM., et al. (2018). Diabetes mellitus-induced long noncoding RNA Dnm3os regulates macrophage functions and inflammation via nuclear mechanisms. Arterioscler Thromb Vasc Biol, 38, 1806–1820.
26.
DasS., ZhangE., SenapatiP., AmaramV., ReddyM.A., StapletonK., et al. (2018). A novel angiotensin II-induced long noncoding RNA giver regulates oxidative stress, inflammation, and proliferation in vascular smooth muscle cells. Circ Res, 123, 1298–1312.
27.
DelicD., EiseleC., SchmidR., BaumP., WiechF., GerlM., et al. (2016). Urinary exosomal miRNA signature in Type II diabetic nephropathy patients. PLoS One 11,e0150154.
28.
DengW., ChenK., LiuS., and WangY. (2019). Silencing circular ANRIL protects HK-2 cells from lipopolysaccharide-induced inflammatory injury through up-regulating microRNA-9. Artif Cells Nanomed Biotechnol, 47, 3478–3484.
29.
DeshpandeS., AbdollahiM., WangM., LantingL., KatoM., and NatarajanR. (2018). Reduced autophagy by a microRNA-mediated signaling cascade in diabetes-induced renal glomerular hypertrophy. Sci Rep 8,6954.
30.
DeshpandeS.D., PuttaS., WangM., LaiJ.Y., BitzerM., NelsonR.G., et al. (2013). Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes, 62, 3151–3162.
31.
DuB., MaL.M., HuangM.B., ZhouH., HuangH.L., ShaoP., et al. (2010). High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett, 584, 811–816.
32.
DuanL.J., DingM., HouL.J., CuiY.T., LiC.J., and YuD.M. (2017). Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARgamma in diabetic nephropathy. Biochem Biophys Res Commun, 484, 598–604.
33.
EissaS., MatboliM., AboushahbaR., BekhetM.M., and SolimanY. (2016). Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease. J Diabetes Complications, 30, 1585–1592.
EspinelE., AgrazI., IbernonM., RamosN., FortJ., and SeronD. (2015). Renal Biopsy in Type 2 Diabetic Patients. J Clin Med, 4, 998–1009.
36.
FanW., PengY., LiangZ., YangY., and ZhangJ. (2019). A negative feedback loop of H19/miR-675/EGR1 is involved in diabetic nephropathy by downregulating the expression of the vitamin D receptor. J Cell Physiol, 234, 17505–17513.
37.
FangM., LiuS., ZhouY., DengY., YinQ., HuL., et al. (2019). Circular RNA involved in the protective effect of losartan on ischemia and reperfusion induced acute kidney injury in rat model. Am J Transl Res, 11, 1129–1144.
38.
FengY., ChenS., XuJ., ZhuQ., YeX., DingD., et al. (2018). Dysregulation of lncRNAs GM5524 and GM15645 involved in highglucoseinduced podocyte apoptosis and autophagy in diabetic nephropathy. Mol Med Rep, 18, 3657–3664.
39.
FischerE., GreshL., ReimannA., and PontoglioM. (2004). Cystic kidney diseases: learning from animal models. Nephrol Dial Transplant, 19, 2700–2702.
40.
GaoY., ChenZ.Y., WangY., LiuY., MaJ.X., and LiY.K. (2017). Long non-coding RNA ASncmtRNA-2 is upregulated in diabetic kidneys and high glucose-treated mesangial cells. Exp Ther Med, 13, 581–587.
41.
GuoG., WangH., YeL., ShiX., YanK., LinK., et al. (2019). Hsa_circ_0000479 as a novel diagnostic biomarker of systemic lupus erythematosus. Front Immunol 10,2281.
42.
GuttmanM., AmitI., GarberM., FrenchC., LinM.F., FeldserD., et al. (2009). Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature, 458, 223–227.
43.
HajarnisS.S., PatelV., AboudehenK., AttanasioM., Cobo-StarkP., PontoglioM., et al. (2015). Transcription Factor Hepatocyte Nuclear Factor-1beta (HNF-1beta) Regulates MicroRNA-200 Expression through a Long Noncoding RNA. J Biol Chem, 290, 24793–24805.
44.
HanJ., LeeY., YeomK.H., KimY.K., JinH., and KimV.N. (2004). The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev, 18, 3016–3027.
45.
HanJ., LeeY., YeomK.H., NamJ.W., HeoI., RheeJ.K., et al. (2006). Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell, 125, 887–901.
46.
HansonR.L., CraigD.W., MillisM.P., YeattsK.A., KobesS., PearsonJ.V., et al. (2007). Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes, 56, 975–983.
47.
HolmanR.R., PaulS.K., BethelM.A., NeilH.A., and MatthewsD.R. (2008). Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med, 359, 1565–1576.
48.
HuC., SunL., XiaoL., HanY., FuX., XiongX., et al. (2015). Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy. Curr Med Chem, 22, 2858–2870.
49.
HuM., WangR., LiX., FanM., LinJ., ZhenJ., et al. (2017). LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with beta-catenin. J Cell Mol Med, 21, 2732–2747.
50.
HuW., HanQ., ZhaoL., and WangL. (2019). Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-beta1. J Cell Physiol, 234, 1469–1476.
51.
HuangS., XuY., GeX., XuB., PengW., JiangX., et al. (2019). Long noncoding RNA NEAT1 accelerates the proliferation and fibrosis in diabetic nephropathy through activating Akt/mTOR signaling pathway. J Cell Physiol, 234, 11200–11207.
52.
IgnarskiM., IslamR., and MullerR.U. (2019). Long Non-Coding RNAs in kidney disease. Int J Mol Sci 20,3276.
53.
InagiR., IshimotoY., and NangakuM. (2014). Proteostasis in endoplasmic reticulum—new mechanisms in kidney disease. Nat Rev Nephrol, 10, 369–378.
54.
JiT.T., WangY.K., ZhuY.C., GaoC.P., LiX.Y., LiJ., et al. (2019). Long noncoding RNA Gm6135 functions as a competitive endogenous RNA to regulate toll-like receptor 4 expression by sponging miR-203-3p in diabetic nephropathy. J Cell Physiol, 234, 6633–6641.
55.
JiangX., and NingQ. (2019). Circular RNAs as novel regulators, biomarkers and potential therapies in fibrosis. Epigenomics, 11, 1107–1116.
56.
JinJ., SunH., ShiC., YangH., WuY., LiW., et al. (2020). Circular RNA in renal diseases. J Cell Mol Med 24,6523.
57.
KanwarY.S., SunL., XieP., LiuF.Y., and ChenS. (2011). A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol, 6, 395–423.
58.
KapranovP., ChengJ., DikeS., NixD.A., DuttaguptaR., WillinghamA.T., et al. (2007). RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science, 316, 1484–1488.
59.
KatoM., DangV., WangM., ParkJ.T., DeshpandeS., KadamS., et al. (2013). TGF-beta induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci Signal 6,ra43.
KatoM., and NatarajanR. (2015). MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets. Ann N Y Acad Sci, 1353, 72–88.
62.
KatoM., and NatarajanR. (2019). Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat Rev Nephrol, 15, 327–345.
63.
KatoM., PuttaS., WangM., YuanH., LantingL., NairI., et al. (2009). TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol, 11, 881–889.
64.
KatoM., WangM., ChenZ., BhattK., OhH.J., LantingL., et al. (2016). An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy. Nat Commun 7,12864.
65.
KatoM., YuanH., XuZ.G., LantingL., LiS.L., WangM., et al. (2006). Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J Am Soc Nephrol, 17, 3325–3335.
66.
KatoM., ZhangJ., WangM., LantingL., YuanH., RossiJ.J., et al. (2007). MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA, 104, 3432–3437.
67.
Kdoqi. (2007). KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis, 49(2 Suppl 2), S12–S154.
68.
KollingM., SeegerH., HaddadG., KistlerA., NowakA., Faulhaber-WalterR., et al. (2018). The Circular RNA ciRs-126 predicts survival in critically Ill patients with acute kidney injury. Kidney Int Rep, 3, 1144–1152.
69.
KropskiJ.A., and BlackwellT.S. (2018). Endoplasmic reticulum stress in the pathogenesis of fibrotic disease. J Clin Invest, 128, 64–73.
70.
LaiJ.Y., LuoJ., O'ConnorC., JingX., NairV., JuW., et al. (2015). MicroRNA-21 in glomerular injury. J Am Soc Nephrol, 26, 805–816.
71.
LeeR.C., FeinbaumR.L., and AmbrosV. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843–854.
72.
LeeY., KimM., HanJ., YeomK.-H., LeeS., BaekS.H., et al. (2004). MicroRNA genes are transcribed by RNA polymerase II. EMBO J, 23, 4051–4060.
73.
LeiX., ZhangL., LiZ., and RenJ. (2018). Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats. Drug Des Devel Ther, 12, 2785–2793.
74.
LelliA., NolanK.A., SantambrogioS., GoncalvesA.F., SchonenbergerM.J., GuinotA., et al. (2015). Induction of long noncoding RNA MALAT1 in hypoxic mice. Hypoxia (Auckl), 3, 45–52.
75.
LeungA., AmaramV., and NatarajanR. (2019). Linking diabetic vascular complications with LncRNAs. Vascul Pharmacol, 114, 139–144.
76.
LeungA., TracC., JinW., LantingL., AkbanyA., SaetromP., et al. (2013). Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res, 113, 266–278.
77.
LiA., PengR., SunY., LiuH., PengH., and ZhangZ. (2018). LincRNA 1700020I14Rik alleviates cell proliferation and fibrosis in diabetic nephropathy via miR-34a-5p/Sirt1/HIF-1alpha signaling. Cell Death Dis 9,461.
78.
LiZ., YuZ., MengX., and YuP. (2018). LncRNA LINC00968 accelerates the proliferation and fibrosis of diabetic nephropathy by epigenetically repressing p21 via recruiting EZH2. Biochem Biophys Res Commun, 504, 499–504.
79.
LinS.P., YeS., LongY., FanY., MaoH.F., ChenM.T., et al. (2016). Circular RNA expression alterations are involved in OGD/R-induced neuron injury. Biochem Biophys Res Commun, 471, 52–56.
80.
LiuJ.Y., YaoJ., LiX.M., SongY.C., WangX.Q., LiY.J., et al. (2014). Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis 5,e1506.
81.
LongJ., BadalS.S., YeZ., WangY., AyangaB.A., GalvanD.L., et al. (2016). Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy. J Clin Invest, 126, 4205–4218.
82.
LongJ., and DaneshF.R. (2018). Values and limitations of targeting lncRNAs in diabetic nephropathy. Diabetes, 67, 552–553.
83.
LuC., ChenB., ChenC., LiH., WangD., TanY., et al. (2020). CircNr1h4 regulates the pathological process of renal injury in salt-sensitive hypertensive mice by targeting miR-155-5p. J Cell Mol Med, 24, 1700–1712.
84.
LuQ., MaZ., DingY., BedaridaT., ChenL., XieZ., et al. (2019). Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-kappaB/p65 regulatory axis. Nat Commun 10,2145.
85.
LundE., and DahlbergJ.E. (2006). Substrate selectivity of exportin 5 and Dicer in the biogenesis of microRNAs. Cold Spring Harbor Symp Quant Biol, 71, 59–66.
86.
LvC., ZhouY.H., WuC., ShaoY., LuC.L., and WangQ.Y. (2015). The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy. Diabetes Metab Res Rev, 31, 717–724.
87.
MaC., QinJ., ZhangJ., WangX., WuD., and LiX. (2020). Construction and analysis of circular RNA molecular regulatory networks in clear cell renal cell carcinoma. Mol Med Rep, 21, 141–150.
88.
MaL., CaoJ., LiuL., DuQ., LiZ., ZouD., et al. (2019). LncBook: a curated knowledgebase of human long non-coding RNAs. Nucleic Acids Res, 47(D1), D128–D134.
89.
MaX., LuC., LvC., WuC., and WangQ. (2016). The Expression of miR-192 and its significance in diabetic nephropathy patients with different urine albumin creatinine ratio. J Diabetes Res 2016,6789402.
90.
MajumderS., HaddenM.J., ThiemeK., BatchuS.N., NivedithaD., ChowdhuryS., et al. (2019). Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease. Diabetologia, 62, 2129–2142.
91.
MengX.M., Nikolic-PatersonD.J., and LanH.Y. (2016). TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol, 12, 325–338.
92.
MiaoF., ChenZ., GenuthS., PatersonA., ZhangL., WuX., et al. (2014). Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes, 63, 1748–1762.
93.
NanA., ChenL., ZhangN., LiuZ., YangT., WangZ., et al. (2017). A novel regulatory network among LncRpa, CircRar1, MiR-671 and apoptotic genes promotes lead-induced neuronal cell apoptosis. Arch Toxicol, 91, 1671–1684.
94.
NiH., LiW., ZhugeY., XuS., WangY., ChenY., et al. (2019). Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p. Int J Cardiol, 292, 188–196.
95.
OuyangQ., HuangQ., JiangZ., ZhaoJ., ShiG.P., and YangM. (2018). Using plasma circRNA_002453 as a novel biomarker in the diagnosis of lupus nephritis. Mol Immunol, 101, 531–538.
96.
ParkJ.-E., HeoI., TianY., SimanshuD.K., ChangH., JeeD., et al. (2011). Dicer recognizes the 5’ end of RNA for efficient and accurate processing. Nature, 475, 201–205.
97.
PengH., ZhongM., ZhaoW., WangC., ZhangJ., LiuX., et al. (2013). Urinary miR-29 correlates with albuminuria and carotid intima-media thickness in type 2 diabetes patients. PLoS One 8,e82607.
98.
PezzolesiM.G., SatakeE., McDonnellK.P., MajorM., SmilesA.M., and KrolewskiA.S. (2015). Circulating TGF-beta1-Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes. Diabetes, 64, 3285–3293.
99.
PuthanveetilP., ChenS., FengB., GautamA., and ChakrabartiS. (2015). Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med, 19, 1418–1425.
100.
PuttaS., LantingL., SunG., LawsonG., KatoM., and NatarajanR. (2012). Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol, 23, 458–469.
101.
QianY., FeldmanE., PennathurS., KretzlerM., and BrosiusF.C., 3rd. (2008). From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes, 57, 1439–1445.
102.
QinW., ChungA.C., HuangX.R., MengX.M., HuiD.S., YuC.M., et al. (2011). TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol, 22, 1462–1474.
103.
RamezaniA., DevaneyJ.M., CohenS., WingM.R., ScottR., KnoblachS., et al. (2015). Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study. Eur J Clin Invest, 45, 394–404.
104.
RavasiT., SuzukiH., PangK.C., KatayamaS., FurunoM., OkunishiR., et al. (2006). Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome. Genome Res, 16, 11–19.
105.
ReddyM.A., ChenZ., ParkJ.T., WangM., LantingL., ZhangQ., et al. (2014). Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA. Diabetes, 63, 4249–4261.
106.
ReidyK., KangH.M., HostetterT., and SusztakK. (2014). Molecular mechanisms of diabetic kidney disease. J Clin Invest, 124, 2333–2340.
107.
ReinhartB.J., SlackF.J., BassonM., PasquinelliA.E., BettingerJ.C., RougvieA.E., et al. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 403, 901–906.
108.
RenG.L., ZhuJ., LiJ., and MengX.M. (2019a). Noncoding RNAs in acute kidney injury. J Cell Physiol, 234, 2266–2276.
109.
RenH., MaX., ShaoY., HanJ., YangM., and WangQ. (2019b). Correlation Between Serum miR-154-5p and osteocalcin in males and postmenopausal females of type 2 diabetes with different urinary albumin creatinine ratios. Front Endocrinol (Lausanne) 10,542.
110.
RenH., WuC., ShaoY., LiuS., ZhouY., and WangQ. (2020). Correlation between serum miR-154-5p and urinary albumin excretion rates in patients with type 2 diabetes mellitus: a cross-sectional cohort study. Front Med, 14, 642–650.
111.
RyuJ., KwonD.H., ChoeN., ShinS., JeongG., LimY.H., et al. (2020). Characterization of circular RNAs in vascular smooth muscle cells with vascular calcification. Mol Ther Nucleic Acids, 19, 31–41.
112.
SallustioF., SerinoG., CostantinoV., CurciC., CoxS.N., De PalmaG., et al. (2013). miR-1915 and miR-1225-5p regulate the expression of CD133, PAX2 and TLR2 in adult renal progenitor cells. PLoS One 8,e68296.
113.
SchorrG.S., FalconeE.A., MorettiD.J., and AndrewsR.D. (2014). First long-term behavioral records from Cuvier's beaked whales (Ziphius cavirostris) reveal record-breaking dives. PLoS One 9,e92633.
114.
SedeekM., MontezanoA.C., HebertR.L., GrayS.P., Di MarcoE., JhaJ.C., et al. (2012). Oxidative stress, Nox isoforms and complications of diabetes—potential targets for novel therapies. J Cardiovasc Transl Res, 5, 509–518.
ShaoY., LvC., WuC., ZhouY., and WangQ. (2016). Mir-217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via Sirt1/HIF-1α signaling pathway. Diabetes Metab Res Rev, 32, 534–543.
117.
ShaoY., RenH., LvC., MaX., WuC., and WangQ. (2017). Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. Endocrine, 55, 130–138.
118.
SimpsonK., WonnacottA., FraserD.J., and BowenT. (2016). MicroRNAs in diabetic nephropathy: from biomarkers to therapy. Curr Diab Rep 16,35.
119.
SoleC., Cortes-HernandezJ., FelipM.L., VidalM., and Ordi-RosJ. (2015). miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. Nephrol Dial Transplant, 30, 1488–1496.
120.
SunS.F., TangP.M.K., FengM., XiaoJ., HuangX.R., LiP., et al. (2018). Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in db/db Mice by Targeting miR-29b. Diabetes, 67, 731–744.
121.
SunY., YangZ., ZhengB., ZhangX.H., ZhangM.L., ZhaoX.S., et al (2017). A Novel Regulatory Mechanism of Smooth Muscle alpha-Actin Expression by NRG-1/circACTA2/miR-548f-5p Axis. Circ Res, 121, 628–635.
122.
TianS., LiuX., FanQ., MaJ., YaoL., and LiY. (2019). Microarray expression and functional analysis of circular RNAs in the glomeruli of NZB/W F1 mice with lupus nephritis. Exp Ther Med, 18, 2813–2824.
123.
TrionfiniP., and BenigniA. (2017). MicroRNAs as master regulators of glomerular function in health and disease. J Am Soc Nephrol, 28, 1686–1696.
124.
TrionfiniP., BenigniA., and RemuzziG. (2015). MicroRNAs in kidney physiology and disease. Nat Rev Nephrol, 11, 23–33.
125.
WangB., Herman-EdelsteinM., KohP., BurnsW., Jandeleit-DahmK., WatsonA., et al. (2010). E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes, 59, 1794–1802.
126.
WangB., KomersR., CarewR., WinbanksC.E., XuB., Herman-EdelsteinM., et al. (2012). Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol, 23, 252–265.
127.
WangG., XueW., JianW., LiuP., WangZ., WangC., et al. (2018). The effect of Hsa_circ_0001451 in clear cell renal cell carcinoma cells and its relationship with clinicopathological features. J Cancer, 9, 3269–3277.
128.
WangJ., PanJ., LiH., LongJ., FangF., ChenJ., et al. (2018). lncRNA ZEB1-AS1 was suppressed by p53 for renal fibrosis in diabetic nephropathy. Mol Ther Nucleic Acids, 12, 741–750.
129.
WangJ.-Y., GaoY.-B., ZhangN., ZouD.-W., WangP., ZhuZ.-Y., et al. (2014). miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Mol Cell Endocrinol, 392, 163–172.
130.
WangM., WangS., YaoD., YanQ., and LuW. (2016). A novel long non-coding RNA CYP4B1-PS1-001 regulates proliferation and fibrosis in diabetic nephropathy. Mol Cell Endocrinol, 426, 136–145.
131.
WangS., ChenX., WangM., YaoD., ChenT., YanQ., et al. (2018). Long Non-Coding RNA CYP4B1-PS1-001 inhibits proliferation and fibrosis in diabetic nephropathy by interacting with nucleolin. Cell Physiol Biochem, 49, 2174–2187.
132.
WangW., DongR., GuoY., HeJ., ShaoC., YiP., et al. (2019). CircMTO1 inhibits liver fibrosis via regulation of miR-17-5p and Smad7. J Cell Mol Med, 23, 5486–5496.
133.
WangX., XuY., ZhuY.C., WangY.K., LiJ., LiX.Y., et al. (2019). LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy. J Cell Physiol, 234, 12926–12933.
134.
WangY.N., ShanK., YaoM.D., YaoJ., WangJ.J., LiX., et al. (2016). Long Noncoding RNA-GAS5: a novel regulator of hypertension-induced vascular remodeling. Hypertension, 68, 736–748.
135.
World Health Organization (WHO). (2016). Global Report on Diabetes. Available at http://apps.who.int/h/iris/bitstream/10665/204871/1/9789241565257_eng.pdf (last accessed on April21, 2016).
136.
WuC., LvC., ChenF., MaX., ShaoY., and WangQ. (2015). The function of miR-199a-5p/Klotho regulating TLR4/NF-κB p65/NGAL pathways in rat mesangial cells cultured with high glucose and the mechanism. Mol Cell Endocrinol, 417, 84–93.
137.
WuC., QinN., RenH., YangM., LiuS., and WangQ. (2018). Metformin Regulating miR-34a Pathway to Inhibit Egr1 in rat mesangial cells cultured with high glucose. Int J Endocrinol 2018,6462793.
138.
XieY., JiaY., CuihuaX., HuF., XueM., and XueY. (2017). Urinary Exosomal MicroRNA profiling in incipient type 2 diabetic kidney disease. J Diabetes Res 2017,6978984.
139.
XiongY., ZhangJ., and SongC. (2019). CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. J Cell Physiol, 234, 10646–10654.
140.
YanB., YaoJ., LiuJ.Y., LiX.M., WangX.Q., LiY.J., et al. (2015). lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res, 116, 1143–1156.
141.
YangH., KanQ.E., SuY., and ManH. (2019). Long Non-Coding RNA CASC2 improves diabetic nephropathy by inhibiting JNK pathway. Exp Clin Endocrinol Diabetes, 127, 533–537.
142.
YaoW., LiY., HanL., JiX., PanH., LiuY., et al. (2018). The CDR1as/miR-7/TGFBR2 Axis Modulates EMT in Silica-Induced Pulmonary Fibrosis. Toxicol Sci, 166, 465–478.
143.
YiH., PengR., ZhangL.Y., SunY., PengH.M., LiuH.D., et al. (2017). LincRNA-Gm4419 knockdown ameliorates NF-kappaB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy. Cell Death Dis 8,e2583.
144.
YuX., HeY., ChenZ., QianY., WangJ., JiZ., et al. (2019). Autologous decellularized extracellular matrix protects against H2O2-induced senescence and aging in adipose-derived stem cells and stimulates proliferation in vitro. Biosci Rep 39,BSR20182137.
145.
YunusovD., AndersonL., DaSilvaL.F., WysockaJ., EzashiT., RobertsR.M., et al. (2016). HIPSTR and thousands of lncRNAs are heterogeneously expressed in human embryos, primordial germ cells and stable cell lines. Sci Rep 6,32753.
146.
ZgheibC., HodgesM.M., HuJ., LiechtyK.W., and XuJ. (2017). Long non-coding RNA Lethe regulates hyperglycemia-induced reactive oxygen species production in macrophages. PLoS One 12,e0177453.
147.
ZhangP., SunY., PengR., ChenW., FuX., ZhangL., et al. (2019). Long non-coding RNA Rpph1 promotes inflammation and proliferation of mesangial cells in diabetic nephropathy via an interaction with Gal-3. Cell Death Dis 10,526.
148.
ZhangY., SunY., PengR., LiuH., HeW., ZhangL., et al. (2018). The Long Noncoding RNA 150Rik promotes mesangial cell proliferation via miR-451/IGF1R/p38 MAPK signaling in diabetic nephropathy. Cell Physiol Biochem, 51, 1410–1428.
149.
ZhongX., ChungA.C., ChenH.Y., MengX.M., and LanH.Y. (2011). Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol, 22, 1668–1681.
150.
ZhouB., and YuJ.W. (2017). A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-beta1. Biochem Biophys Res Commun, 487, 769–775.
151.
ZhouL., XuD.Y., ShaW.G., ShenL., LuG.Y., and YinX. (2015). Long non-coding MIAT mediates high glucose-induced renal tubular epithelial injury. Biochem Biophys Res Commun, 468, 726–732.
152.
ZhouQ., ChungA.C., HuangX.R., DongY., YuX., and LanH.Y. (2014). Identification of novel long noncoding RNAs associated with TGF-beta/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Am J Pathol, 184, 409–417.
153.
ZhuL., RenT., ZhuZ., ChengM., MouQ., MuM., et al. (2018). Thymosin-beta4 mediates hepatic stellate cell activation by interfering with CircRNA-0067835/miR-155/FoxO3 signaling pathway. Cell Physiol Biochem, 51, 1389–1398.
154.
ZouZ.Q., XuJ., LiL., and HanY.S. (2015). Down-regulation of SENCR promotes smooth muscle cells proliferation and migration in db/db mice through up-regulation of FoxO1 and TRPC6. Biomed Pharmacother, 74, 35–41.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
